Healix Pathology, LLP

Dr. Kevin P. Rosenblatt

M.D., Ph.D.

Dr. Rosenblatt has more than 30 years of clinical and biomedical research and development experience in multiple settings, including academia, biotech, startups, and clinical practice, and he has published over 80 papers and book chapters on cancer and neuronal biology, biomarker development, and clinical genomics and proteomics. Currently, he is President and Medical Director of Consultative Genomics, PLLC, a molecular pathology group specializing in Genomic and Proteomic clinical testing as applied to chronic disease, population health management, and personalized medicine. 

He is also currently Chief Medical Officer and Chief Scientific Officer of NX Prenatal, a prenatal diagnostics company developing assays for adverse pregnancy outcomes and conditions such as preterm birth. Previously, he was Chief Scientific Officer, Chief Medical Officer, and Clinical Laboratory Director at CompanionDx’s CLIA/CAP/NYSDH- certified reference lab. 

an innovative and simple platform ...

Among other appointments, he has served as Director of the Center for Clinical Proteomics at the Brown Foundation Institute of Molecular Medicine, as well as the Director of the UT Health Science Center at Houston’s Center for Clinical and Translational Sciences Proteomics Core, and was Associate Professor in the Division of Oncology, Department of Internal Medicine at UT Health and the McGovern Medical School and Associate, Adjunct Professor in the School of Health Professions at the MD Anderson Cancer Center, both in Houston.